社区人群腺瘤切除后结直肠癌及死亡长期风险
基于大型社区综合医疗系统2004至2010年基线结肠镜数据,随访至2017年底,比较无腺瘤、低风险腺瘤和高风险腺瘤患者的结直肠癌及死亡风险。高风险腺瘤患者结直肠癌和死亡风险显著升高,低风险腺瘤患者风险无显著增加。
要点
- 高风险腺瘤患者结直肠癌风险显著升高(HR 2.61)。
- 高风险腺瘤患者结直肠癌相关死亡风险显著升高(HR 3.94)。
- 低风险腺瘤患者结直肠癌及死亡风险无显著增加。
核心结论
- 高风险腺瘤与结直肠癌及相关死亡风险增加相关,支持早期结肠镜监测。
- 低风险腺瘤与结直肠癌或相关死亡风险无显著增加。
研究设计与样本
- 共64,422例符合条件患者,女性占54.3%,平均年龄61.6±7.1岁,中位随访8.1年。
- 按基线结肠镜发现分为无腺瘤组(45,881例)、低风险腺瘤组(10,978例)和高风险腺瘤组(7,563例)。
- 采用Cox回归校正混杂因素,比较高风险和低风险腺瘤组与无腺瘤组的结直肠癌及死亡风险。
主要发现
- 高风险腺瘤组相比无腺瘤组,结直肠癌风险升高(HR 2.61;95%CI 1.87-3.63)。
- 高风险腺瘤组相比无腺瘤组,结直肠癌相关死亡风险升高(HR 3.94;95%CI 1.90-6.56)。
- 低风险腺瘤组相比无腺瘤组,结直肠癌风险无显著增加(HR 1.29;95%CI 0.89-1.88)。
- 低风险腺瘤组相比无腺瘤组,结直肠癌相关死亡风险无显著增加(HR 0.65;95%CI 0.19-2.18)。
临床怎么用
- 高风险腺瘤患者应接受早期结肠镜监测。
- 低风险腺瘤患者可参考现行监测指南,无需过度强化随访。
局限性
- 随访时间最长14年,中位随访8.1年,更长期风险未知。
- 观察性设计可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The long-term risks of colorectal cancer (CRC) and CRC-related death following adenoma removal are uncertain. Data are needed to inform evidence-based surveillance guidelines, which vary in follow-up recommendations for some polyp types. Using data from a large, community-based integrated health care setting, we examined the risks of CRC and related death by baseline colonoscopy adenoma findings. METHODS: Participants at 21 medical centers underwent baseline colonoscopies from 2004 through 2010; findings were categorized as no-adenoma, low-risk adenoma, or high-risk adenoma. Participants were followed until the earliest of CRC diagnosis, death, health plan disenrollment, or December 31, 2017. Risks of CRC and related deaths among the high- and low-risk adenoma groups were compared with the no-adenoma group using Cox regression adjusting for confounders. RESULTS: Among 186,046 patients, 64,422 met eligibility criteria (54.3% female; mean age, 61.6 ± 7.1 years; median follow-up time, 8.1 years from the baseline colonoscopy). Compared with the no-adenoma group (45,881 patients), the high-risk adenoma group (7563 patients) had a higher risk of CRC (hazard ratio [HR] 2.61; 95% confidence interval [CI] 1.87-3.63) and related death (HR 3.94; 95% CI 1.90-6.56), whereas the low-risk adenoma group (10,978 patients) did not have a significant increase in risk of CRC (HR 1.29; 95% CI 0.89-1.88) or related death (HR 0.65; 95% CI 0.19-2.18). CONCLUSIONS: With up to 14 years of follow-up, high-risk adenomas were associated with an increased risk of CRC and related death, supporting early colonoscopy surveillance. Low-risk adenomas were not associated with a significantly increased risk of CRC or related deaths. These results can inform current surveillance guidelines for high- and low-risk adenomas.
引用
- Lee JK, Jensen CD, Levin TR, et al. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2019. PMID: 31589872. doi:10.1053/j.gastro.2019.09.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。